Education
About Us
Working with TipRanks
Follow Us
Dr. Hoenle AG (DE:HNL)
XETRA:HNL
HNL Stock Chart & Stats
€7.26
-€0.20(-2.86%)
At close: 4:00 PM EST
€7.26
-€0.20(-2.86%)
Day’s Range― - ―
52-Week Range€6.50 - €13.00
Previous CloseN/A
Volume3.05K
Average Volume (3M)6.13K
Market Cap
€45.10M
Enterprise Value€102.48M
Total Cash (Recent Filing)€5.91M
Total Debt (Recent Filing)€50.80M
Price to Earnings (P/E)―
Beta0.71
Next Earnings
Dec 05, 2025EPS EstimateN/A
Last Dividend Ex-Date
Mar 25, 2022Dividend YieldN/A
Share Statistics
EPS (TTM)-0.15
Shares Outstanding6,062,930
10 Day Avg. Volume3,193
30 Day Avg. Volume6,130
Financial Highlights & Ratios
PEG Ratio-0.26
Price to Book (P/B)0.89
Price to Sales (P/S)0.72
P/FCF Ratio20.64
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Dr. Hoenle AG News
HNL FAQ
What was Dr. Hoenle AG’s price range in the past 12 months?
Dr. Hoenle AG lowest stock price was €6.50 and its highest was €13.00 in the past 12 months.
What is Dr. Hoenle AG’s market cap?
Dr. Hoenle AG’s market cap is €45.10M.
When is Dr. Hoenle AG’s upcoming earnings report date?
Dr. Hoenle AG’s upcoming earnings report date is Dec 05, 2025 which is in 21 days.
How were Dr. Hoenle AG’s earnings last quarter?
Dr. Hoenle AG released its earnings results on Aug 07, 2025. The company reported -€0.15 earnings per share for the quarter, missing the consensus estimate of €0.05 by -€0.2.
Is Dr. Hoenle AG overvalued?
According to Wall Street analysts Dr. Hoenle AG’s price is currently Overvalued.
Does Dr. Hoenle AG pay dividends?
Dr. Hoenle AG pays a Annually dividend of €0.2 which represents an annual dividend yield of N/A. See more information on Dr. Hoenle AG dividends here
What is Dr. Hoenle AG’s EPS estimate?
Dr. Hoenle AG’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Dr. Hoenle AG have?
Dr. Hoenle AG has 6,062,930 shares outstanding.
What happened to Dr. Hoenle AG’s price movement after its last earnings report?
Dr. Hoenle AG reported an EPS of -€0.15 in its last earnings report, missing expectations of €0.05. Following the earnings report the stock price went down -0.713%.
Which hedge fund is a major shareholder of Dr. Hoenle AG?
Currently, no hedge funds are holding shares in DE:HNL
Dr. Hoenle AG Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-28.44%
12-Months-Change
Fundamentals
Return on Equity
-15.84%
Trailing 12-Months
Asset Growth
-11.57%
Trailing 12-Months
Company Description
Dr. Hoenle AG
Dr. Hoenle AG (HNL) is a leading provider of industrial UV technology, specializing in the development and production of high-quality UV systems for various applications, including printing, coatings, adhesives, and disinfection. The company operates primarily in the sectors of UV curing technology, UV systems for water treatment, and UV disinfection solutions, catering to a diverse range of industries such as automotive, healthcare, and manufacturing. HNL is known for its innovative products that enhance efficiency and sustainability in industrial processes.
Technical Analysis
Options Prices
Currently, No data available
---